Latest filing published 20 Jun 2024 for Marinus Pharmaceuticals, INC..
Filing timeline
BuySaleInsider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Charles Austin: trading record in brief
Charles Austin, listed as board member, appears in our data through filings on Marinus Pharmaceuticals, Inc. shares, published by SEC (Form 4). Between 4 February 2022 and 18 June 2024, the trades on record add up to 5 filings.
Every open-market trade on record is a sale: 1 sale worth €6,453. Other entries cover 4 share grants.
The newest entry dates from 20 June 2024: a share grant, in Marinus Pharmaceuticals, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Charles Austin
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,300 shares0Common StockSEC:0001415889-24-017633:0
- 4,600 shares0Common StockSEC:0001415889-24-001596:0
- 1,073 shares@ US$6.49100.0% of flowCommon StockSEC:0001415889-23-002161:0
- 3,600 shares0Common StockSEC:0001415889-23-001548:0
- 2,750 shares0Common StockSEC:0001104659-22-012780:0
5 of 5 declarations
